A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
Titel:
A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy
Auteur:
Fizazi, K. Ulys, A. Sengeløv, L. Moe, M. Ladoire, S. Thiery-Vuillemin, A. Flechon, A. Guida, A. Bellmunt, J. Climent, M.A. Chowdhury, S. Dumez, H. Matouskova, M. Penel, N. Liutkauskiene, S. Stachurski, L. Sternberg, C.N. Baton, F. Germann, N. Daugaard, G.